AMPE insider filings

Ampio Pharmaceuticals, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-06-13. Screen AMPE transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for AMPE between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Ampio Pharmaceuticals, Inc.

FiledFormInsiderReported transactionsSource
2023-06-134BUCHI J KEVIN — DirectorPurchase (P): 21,858 @ $0.29EDGAR
2023-06-094BUCHI J KEVIN — DirectorPurchase (P): 25,000 @ $0.30EDGAR
2023-05-264MARTINO MICHAEL A — CEO, DirectorPurchase (P): 76,890 @ $0.29EDGAR
2023-05-174BUCHI J KEVIN — DirectorPurchase (P): 32,534 @ $0.27EDGAR
2023-05-164BUCHI J KEVIN — DirectorPurchase (P): 23,440 @ $0.24 · Purchase (P): 44,026 @ $0.25EDGAR
2023-05-124Stevens David R — DirectorPurchase (P): 25,000 @ $0.22 · Purchase (P): 25,000 @ $0.21 · Purchase (P): 45,000 @ $0.22EDGAR
2022-03-024JOBES ELIZABETH VARKI — DirectorGrant/award (A): 150,000 (derivative) @ $0EDGAR
2022-02-104Bar-Or David — DirectorGrant/award (A): 75,000 (derivative) @ $0EDGAR
2022-01-044Cherevka Holli — PRESIDENT AND COOTax withholding (F): 47,200 @ $0.57EDGAR
2022-01-044STOKELY DAN — CFOTax withholding (F): 22,914 @ $0.57EDGAR
2022-01-044MACALUSO MICHAEL — DirectorTax withholding (F): 68,400 @ $0.57EDGAR
2022-01-034Giles Richard B — DirectorGrant/award (A): 75,000 (derivative) @ $0EDGAR
2022-01-034Stevens David R — DirectorGrant/award (A): 75,000 (derivative) @ $0EDGAR
2022-01-034MARTINO MICHAEL A — INTERIM CHAIRMAN AND CEO, DirectorGrant/award (A): 250,000 (derivative) @ $0EDGAR
2022-01-034BUCHI J KEVIN — DirectorGrant/award (A): 75,000 (derivative) @ $0EDGAR
2022-01-034COELHO PHILIP H — DirectorGrant/award (A): 75,000 (derivative) @ $0EDGAR
2021-11-244MARTINO MICHAEL A — INTERIM CHAIRMAN AND CEO, DirectorGrant/award (A): 750,000 (derivative) @ $0EDGAR
2021-10-284Cherevka Holli — PRESIDENT AND COOTax withholding (F): 41,980 @ $1.64EDGAR
2021-10-284STOKELY DAN — CFOTax withholding (F): 28,127 @ $1.64EDGAR
2021-10-284MACALUSO MICHAEL — CEO, DirectorTax withholding (F): 43,470 @ $1.64EDGAR
2021-10-254MARTINO MICHAEL A — DirectorGrant/award (A): 150,000 (derivative) @ $0EDGAR
2021-10-254BUCHI J KEVIN — DirectorGrant/award (A): 150,000 (derivative) @ $0EDGAR
2021-10-154Bar-Or David — DirectorGrant/award (A): 120,000 (derivative) @ $0EDGAR
2021-10-154Giles Richard B — DirectorGrant/award (A): 120,000 (derivative) @ $0EDGAR
2021-10-154Stevens David R — DirectorGrant/award (A): 120,000 (derivative) @ $0EDGAR
2021-10-154COELHO PHILIP H — DirectorGrant/award (A): 120,000 (derivative) @ $0EDGAR
2021-10-134Cherevka Holli — CHIEF OPERATING OFFICERGrant/award (A): 500,000 @ $0EDGAR
2021-10-134STOKELY DAN — CFOGrant/award (A): 335,000 @ $0EDGAR
2021-10-134MACALUSO MICHAEL — CEO, DirectorGrant/award (A): 950,000 @ $0EDGAR
2021-06-294STOKELY DAN — CFOOption exercise (M): 22,500 @ $0.43 · Sale (S): 22,500 @ $1.79 · Option exercise (M): 22,500 (derivative) @ $0EDGAR
2021-05-254Cherevka Holli — CHIEF OPERATING OFFICEROption exercise (M): 2,603 @ $0.51 · Sale (S): 2,603 @ $2 · Option exercise (M): 2,603 (derivative) @ $0EDGAR
2021-05-254COELHO PHILIP H — DirectorOption exercise (M): 6,737 @ $0.40 · Sale (S): 6,737 @ $2 · Option exercise (M): 6,737 (derivative) @ $0EDGAR
2021-05-194STOKELY DAN — CFOOption exercise (M): 35,000 @ $0.43 · Sale (S): 35,000 @ $1.83 · Option exercise (M): 35,000 (derivative) @ $0EDGAR
2021-04-294Cherevka Holli — CHIEF OPERATING OFFICEROption exercise (M): 30,000 @ $0.51 · Option exercise (M): 44,631 @ $0.51 · Sale (S): 74,631 @ $2 · Option exercise (M): 30,000 (derivative) @ $0.51 · Option exercise (M): 44,631 (derivative) @ $0.51EDGAR
2021-04-294COELHO PHILIP H — DirectorOption exercise (M): 20,000 @ $0.40 · Sale (S): 20,000 @ $2 · Option exercise (M): 20,000 (derivative) @ $0.40EDGAR
2021-04-294COELHO PHILIP H — DirectorOption exercise (M): 3,263 @ $0.40 · Sale (S): 3,263 @ $2 · Option exercise (M): 3,263 (derivative) @ $0.40EDGAR
2021-03-174STOKELY DAN — CFOOption exercise (M): 40,000 @ $0.43 · Sale (S): 40,000 @ $1.83 · Option exercise (M): 40,000 (derivative) @ $0EDGAR
2021-02-174STOKELY DAN — CFOOption exercise (M): 42,000 @ $2.55 · Option exercise (M): 10,500 @ $2.55 · Tax withholding (F): 24,185 @ $2.55 · Option exercise (M): 42,000 (derivative) @ $0 · Option exercise (M): 10,500 (derivative) @ $0EDGAR
2021-01-054Bar-Or David — DirectorGrant/award (A): 13,513 @ $1.48EDGAR
2021-01-054Giles Richard B — DirectorGrant/award (A): 13,513 @ $1.48EDGAR
2021-01-054Stevens David R — DirectorGrant/award (A): 13,513 @ $1.48EDGAR
2021-01-054COELHO PHILIP H — DirectorGrant/award (A): 13,513 @ $1.48EDGAR
2020-12-214Cherevka Holli — CHIEF OPERATING OFFICERGrant/award (A): 10,000 (derivative) @ $0 · Disposition to issuer (D): 70,598 (derivative) @ $0 · Grant/award (A): 55,000 (derivative) @ $0EDGAR
2020-12-214STOKELY DAN — CFOGrant/award (A): 20,000 (derivative) @ $0EDGAR
2020-12-214MACALUSO MICHAEL — CEO, DirectorGrant/award (A): 50,000 (derivative) @ $0EDGAR
2020-12-154Giles Richard B — DirectorGrant/award (A): 36,000 (derivative) @ $0EDGAR
2020-12-154Bar-Or David — DirectorGrant/award (A): 36,000 (derivative) @ $0EDGAR
2020-12-154Stevens David R — DirectorGrant/award (A): 36,000 (derivative) @ $0EDGAR
2020-12-154COELHO PHILIP H — DirectorGrant/award (A): 36,000 (derivative) @ $0EDGAR
2020-11-184Bar-Or David — DirectorGrant/award (A): 300,000 (derivative) @ $0EDGAR

Recent 8-K events — Ampio Pharmaceuticals, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2025-01-298-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2024-03-258-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2024-02-288-K1.02 — Termination of a Material Definitive Agreement
9.01 — Financial Statements and Exhibits
EDGAR
2024-02-158-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2024-01-258-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2024-01-118-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2023-11-028-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2023-10-278-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2023-10-068-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2023-10-048-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=AMPE returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs